The Fact About semaglutude Weeks 13-16 Bundle That No One Is Suggesting
The trial achieved both of those its Main endpoints, with semaglutide 2.4 mg demonstrating statistically considerable and top-quality improvements in liver fibrosis without having worsening of steatohepatitis, and resolution of steatohepatitis without any worsening of liver fibrosis in people with MASH in comparison to placebo.1What's this? Check o